CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma

by Robyn T. Sussman, Jo Lynne Rokita, Jo Lynne Rokita, Kevin Huang, Pichai Raman, Pichai Raman, Komal S. Rathi, Komal S. Rathi, Daniel Martinez, Kristopher R. Bosse, Kristopher R. Bosse, Maria Lane, Lori S. Hart, Tricia Bhatti, Bruce Pawel, John M. Maris, John M. Maris
Published 2020-03-01